Dialysis: outcome and complications. Introduction Outcomes – 20%+ of dialysis patients die each year, 3YS diabetics ~50% Technical complications –PD –Haemo.

Slides:



Advertisements
Similar presentations
Blood pressure and mortality risk in peritoneal dialysis patients in England and Wales Udaya P.Udayaraj, R.Steenkamp, F.Caskey, D.Ansell, C.Tomson UK Renal.
Advertisements

Cardiovascular disease and vascular calcification in CKD
Cardiovascular Disease In CKD: Is It for Children
Cardiac Risk In ESRD Patient
Multicenter database of clinical course of CKD patients Internal Medicine Jang Hye Ryoun.
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
The PREVEND Study: Screening for micro-albuminuria
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
CKD in individuals with CKD
DIABETIC NEPHROPATHY MAY 2013 DR RAMESH B NAIK FRCP.
Lynda K. Ball, MSN, RN, CNN Quality Improvement Director Northwest Renal Network Improving Sub-Optimal Hemoglobins October 14, 2010.
Measurement and preservation of residual renal function (RRF) in haemodialysis patients Elizabeth Lindley and David Keane Leeds Teaching Hospitals NHS.
Journal Club EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events – EVOLVE NEJM Dec 2012 Yuvaraj Thangaraj, M.D. Nephrology Fellow Division.
Hypertension and chronic kidney disease in older people Dr Rick Fielding Consultant Renal Medicine Brighton & Sussex University Hospitals.
Reference Avram MM, et al. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend.
What is the Role of Peritoneal Dialysis in Optimising ESRD Patient Outcomes?
NHANES III Prevalence of Hypertension* According to BMI
Treatment of Hypertension in Patients on Hemodialysis
Lesley Stevens MD Tufts-New England Medical Center
Feast or Famine: Survival and Chronic Kidney Disease Kerin Worley and Deb Gipson UNC Chapel Hill April, 2004.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
Gerard Dou, The Dropsical Woman, 1663, Louvre, Paris Peer Report: Dialysis Care & Outcomes in the U.S., 2014 Executive Summary.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
CKD: the primary/secondary care interface Daniel Ford Consultant Renal Physician UHCW.
RENAL DISEASE IN DIABETES
Widening the Circles of Inclusion The National Renal Service Dr Donal O’Donoghue Co-Chair Renal Advisory Group 4 July 2006.
Randomized, double-blind, multicenter, controlled trial.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
Cardiovascular Risk In Chronic Kidney Disease Dr Ginny Quan.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
James Heaf Herlev Hospital University of Copenhagen
The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)
A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the.
Mamdouh Albaqumi, MD, FASN Nephrology Section Department of Medicine King Faisal Specialist Hospital Hypertension and CKD in the Pregnancy.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Matthew R. Weir, MD Professor and Director Division of Nephrology University of Maryland School of Medicine Baltimore, Maryland Kidney Disease and Dialysis.
Diabetes and the Kidney Richard Kingston Department of Renal Medicine Kent and Canterbury Hospital.
High Coronary Calcification Scores Predict Mortality in Pre-Dialysis CKD Patients Reference: Haas MH. The risk of death in patients with a high coronary.
Date of download: 5/29/2016 From: The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow- up of the Modification.
Cardiovascular complications in Chronic Kidney Disease Nihil Chitalia Consultant Nephrologist Epsom and St. Heliers’ University Hospital NHS trust - Hopes.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Hypertension J Am Coll Cardiol. 2006;48(8):
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Antonio Coca, MD, PhD, FRCP, FESC
UK Renal Registry 18th Annual Report
All-cause mortality by treatment group
Intensive Hemodialysis: Applied Clinical Practice
Copyright © 2007 American Medical Association. All rights reserved.
Hospital admissions per patient, by modality figure 5
Current and future management of diabetic renal failure
Early Systolic Blood Pressure Changes in Incident Hemodialysis Patients Are Associated with Mortality in the First Year Kidney Blood Press Res 2012;35:663–670.
Section 5: Configuration of healthcare to manage CKD
Level of risk factor control in the overall sample and by gender
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
UK Renal Registry 14th Annual Report
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Prevalence of cardiovascular risk factors compared with the Canadian population. Prevalence of cardiovascular risk factors compared with the Canadian population.
Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.
Presentation transcript:

Dialysis: outcome and complications

Introduction Outcomes – 20%+ of dialysis patients die each year, 3YS diabetics ~50% Technical complications –PD –Haemo Cardiovascular

Peritoneal dialysis Complications –Technical failure, obesity, operated abdomen Peritonitis ~ 1:24 treatment months –Staph spp –Pseud spp –Candida Scerosing peritonitis

Haemodialysis Access related –Evidence base for starting with secure access, morbidity and mortality 3-5x (nutrition, infection) Outcomes –Haemo more efficient –no superiority of one technique in outcome- based trials

Cardiovascular Risk Foley RN et al. AJKD 1998; 32:S112-S119

38% % UK Registry 2002 Cardiovascular mortality in HD Prevalent HD patients % 7%

Cardiovascular risk in renal patients Conventional risk factors Hypertension Diabetes Age Gender Lipids Smoking Physical activity Specific to renal Hyperparathyroidism Phosphate Vascular calcification Vascular stiffness Renal anaemia Homocysteine Oxidative stress Uraemic factors?

Epidemiology: Cholesterol – do renal patients obey the normal rules? Lowrie AJKD 15,

Hypertension and mortality in HD; the controversy Port F et al AJKD 1999;33:507 RR of mortality to predialysis systolic BP, reference group prevalent HD patients USRDS Charra et al KI 1992:41;1286 Survival rates as a function of Mean arterial pressure at 5, 10, 15 y 445 patients on long-slow HD * * *

Pulse Pressure in Haemodialysis patients Tozawa et al. Kidney International 61, Feb 2002;

Hazard ratio for mortality with Pulse Pressure After adjustment for systolic blood pressure; *p<0.001 * * * * * * * * * * * * * * ** *

Prevalence of Hypertension in hemodialysis % % % Banerjee D et al AJKD 2000;583 Banerjee D et al JASN 2001; % % Gambro Miami Brighton UK; Age,60y

LCC: BP Control at presentation(%)

Blood pressure in the LCC

LCC: Mean number of antihypertensives NEJM 2001: 345;851

BP Control in CKD

Pulse Pressure >80 mm Hg is associated with poorer outcome PP<80 PP>80 Log Rank test p<0.05 PP<80 SGH low clearance clinic n=329

Inhibition of RAAS is associated with improved outcome in CKD 4/5 SGH On ACEI/ARB Log Rank test p<0.05 Not on ACEI/ARB Low clearance clinic at St Georges Hospital n=329 mean follow up 250 days